Results 21 to 30 of about 3,491 (198)

Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency

open access: yesMolecular Genetics and Metabolism Reports, 2021
Introduction: A reliable biomarker is urgently needed in the diagnosis and management of acid sphingomyelinase deficiency (ASMD, also known as Niemann Pick A, A/B, and B).
Margo Sheck Breilyn   +3 more
doaj   +1 more source

case report of ASMD Niemann pick disease

open access: yesInternational journal of health sciences, 2022
Niemann Pick Disease  is a rare  disorder of lysosomal storage of the lipid sphingomyelin and foam cell infiltration of tissues presenting with varying degrees of severity.  metabolic abnormalities of two types responsible for causing  NPD.  acid sphingomyelinase deficiency is  the first metabolic abnormality  causing NPD type A and B and and second is
V S Hamsa   +3 more
openaire   +1 more source

The landscape of acid sphingomyelinase deficiency in a new therapeutic era: insights from experts in the Gulf region

open access: yesJournal of Biochemical and Clinical Genetics, 2023
Acid sphingomyelinase deficiency (ASMD) is an autosomal-recessive progressive multiorgan metabolic disorder due to pathogenic variants in the sphingomyelin phosphodiesterase 1 gene.
Moeenaldeen AlSayed   +6 more
doaj   +1 more source

Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective

open access: yesScientific Reports, 2021
Acid sphingomyelinase deficiency (ASMD), historically known as Niemann–Pick disease (NPD) types A, A/B, and B, is a rare, progressive, potentially fatal lysosomal storage disease with a spectrum of phenotypes.
Robin Pokrzywinski   +7 more
doaj   +1 more source

Cross-media Storytelling Strategy Utilizing N-Screen Service: Focusing on ASMD

open access: yesThe Journal of the Korea Contents Association, 2014
Donghee Shin, Hee-Kyung Kim
exaly   +3 more sources

Neonatal cholestasis is an early liver manifestation of children with acid sphingomyelinase deficiency

open access: yesBMC Gastroenterology, 2022
Background Patients with acid sphingomyelinase deficiency (ASMD) may be referred to a hepatologist for liver manifestations. This study summarized the liver manifestations of patients with ASMD in the early disease course.
Neng-Li Wang   +6 more
doaj   +1 more source

Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Acid sphingomyelinase deficiency (ASMD) is a lysosomal disorder caused by deficiency of acid sphingomyelinase (ASM) leading to the accumulation of sphingomyelin (SM) in a variety of cell types.
Francyne Kubaski   +27 more
doaj   +1 more source

Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)

open access: yesOrphanet Journal of Rare Diseases, 2023
Background Acid Sphingomyelinase Deficiency (ASMD) is a rare autosomal recessive disorder caused by mutations in the SMPD1 gene. This rarity contributes to misdiagnosis, delayed diagnosis and barriers to good care.
Tarekegn Geberhiwot   +21 more
doaj   +1 more source

Concurrent Computing with Shared Replicated Memory [PDF]

open access: yes, 2019
The behavioural theory of concurrent systems states that any concurrent system can be captured by a behaviourally equivalent concurrent Abstract State Machine (cASM).
A Blass   +16 more
core   +2 more sources

Home - About - Disclaimer - Privacy